Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Pernthaler

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Nuclear Medicine|January 25, 2020
A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT: A Special Aspect in Imaging Local Recurrence: ReplyBirgit Pernthaler, Herbert Kvaternik, Reingard M Aigner
Scientific Reports|December 9, 2023
The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CTTina Nazerani-Zemann, Birgit Pernthaler, Gerold Schwantzer, et al.
Clinical Nuclear Medicine|June 3, 2021
Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CTFriedrich Weitzer, Tina Nazerani-Hooshmand, Reingard Maria Aigner, et al.
Clinical Nuclear Medicine|December 5, 2022
18F-FDG PET/CT in Primary Mesothelioma of the LiverBirgit Pernthaler, Luka Brcic, Reingard Maria Aigner, et al.
Scientific Reports|May 22, 2023
Diagnostic value of two-time point [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in the primary staging of untreated prostate cancerFriedrich Weitzer, Birgit Pernthaler, Elisabeth Plhak, et al.
Clinical Nuclear Medicine|December 18, 2023
A Rare Case of Thyroid SarcoidosisTina Nazerani-Zemann, Birgit Pernthaler, Luca Abete, et al.
Clinical Nuclear Medicine|April 7, 2021
18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor SyndromeTina Nazerani Hooshmand, Birgit Pernthaler, Kinga Szurian, et al.
Scientific Reports|February 4, 2022
Diagnostic value of F-18 FDG PET/CT in fever or inflammation of unknown origin in a large single-center retrospective studyFriedrich Weitzer, Tina Nazerani Hooshmand, Birgit Pernthaler, et al.
Nuklearmedizin. Nuclear Medicine|January 4, 2023
F18-FDG PET/CT in a patient with Antisynthetase SyndromeTina Nazerani-Zemann, Susanne Stanzel, Christian Gstettner, et al.
Clinical Nuclear Medicine|October 21, 2020
Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CTBirgit Pernthaler, Tina Nazerani Hooshmand, Jasminka Igrec, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|January 25, 2020
A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT: A Special Aspect in Imaging Local Recurrence: ReplyBirgit Pernthaler, Herbert Kvaternik, Reingard M Aigner
Scientific Reports|December 9, 2023
The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CTTina Nazerani-Zemann, Birgit Pernthaler, Gerold Schwantzer, et al.
Clinical Nuclear Medicine|June 3, 2021
Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CTFriedrich Weitzer, Tina Nazerani-Hooshmand, Reingard Maria Aigner, et al.
Clinical Nuclear Medicine|December 5, 2022
18F-FDG PET/CT in Primary Mesothelioma of the LiverBirgit Pernthaler, Luka Brcic, Reingard Maria Aigner, et al.
Scientific Reports|May 22, 2023
Diagnostic value of two-time point [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in the primary staging of untreated prostate cancerFriedrich Weitzer, Birgit Pernthaler, Elisabeth Plhak, et al.
Clinical Nuclear Medicine|December 18, 2023
A Rare Case of Thyroid SarcoidosisTina Nazerani-Zemann, Birgit Pernthaler, Luca Abete, et al.
Clinical Nuclear Medicine|April 7, 2021
18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor SyndromeTina Nazerani Hooshmand, Birgit Pernthaler, Kinga Szurian, et al.
Scientific Reports|February 4, 2022
Diagnostic value of F-18 FDG PET/CT in fever or inflammation of unknown origin in a large single-center retrospective studyFriedrich Weitzer, Tina Nazerani Hooshmand, Birgit Pernthaler, et al.
Nuklearmedizin. Nuclear Medicine|January 4, 2023
F18-FDG PET/CT in a patient with Antisynthetase SyndromeTina Nazerani-Zemann, Susanne Stanzel, Christian Gstettner, et al.
Clinical Nuclear Medicine|October 21, 2020
Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CTBirgit Pernthaler, Tina Nazerani Hooshmand, Jasminka Igrec, et al.
Pageof 2